{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:01:39Z","timestamp":1790532099849,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110051","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T02:19:04Z","timestamp":1593656344000},"page":"110051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole"],"prefix":"10.1016","volume":"143","author":[{"given":"James J.","family":"DiNicolantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Barroso-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110051_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mehy.2020.110051_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"190","key":"10.1016\/j.mehy.2020.110051_b0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"15","author":"Escher","year":"2020","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.it.2009.04.001","article-title":"A(2B) adenosine receptors in immunity and inflammation","volume":"30","author":"Hasko","year":"2009","journal-title":"Trends Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2020.110051_b0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1100\/tsw.2011.22","article-title":"Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor","volume":"3","author":"Milne","year":"2011","journal-title":"Sci World J"},{"issue":"30","key":"10.1016\/j.mehy.2020.110051_b0030","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2174\/0929867325666180313110254","article-title":"A2A adenosine receptor agonists and their potential therapeutic applications. An update","volume":"25","author":"Guerrero","year":"2018","journal-title":"Curr Med Chem"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2020.110051_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vph.2009.12.008","article-title":"Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement","volume":"52","author":"Umapathy","year":"2010","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.mehy.2020.110051_b0040","doi-asserted-by":"crossref","unstructured":"Fredholm BB, Zhang Y, van dP, I. Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol 1996 August;354(3):262-7.","DOI":"10.1007\/BF00171056"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0045","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1086\/315084","article-title":"Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram","volume":"180","author":"Sullivan","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1006\/bbrc.1994.1314","article-title":"Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells","volume":"199","author":"Iwamoto","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.mehy.2020.110051_b0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jcp.24568","article-title":"Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells","volume":"229","author":"Hassanian","year":"2014","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc6990","article-title":"Bench-to-bedside review: adenosine receptors\u2013promising targets in acute lung injury?","volume":"12","author":"Schepp","year":"2008","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0065","doi-asserted-by":"crossref","first-page":"L259","DOI":"10.1152\/ajplung.00395.2011","article-title":"The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats","volume":"303","author":"Folkesson","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0070","doi-asserted-by":"crossref","first-page":"L497","DOI":"10.1152\/ajplung.00086.2013","article-title":"Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury","volume":"306","author":"Gonzales","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1165\/rcmb.2012-0351OC","article-title":"Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injury","volume":"48","author":"Aggarwal","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000365","article-title":"Pentoxifylline for vascular health: a brief review of the literature","volume":"3","author":"McCarty","year":"2016","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000331979004100401","article-title":"Effect of pentoxifylline on the flow of polymorphonuclear leukocytes through a model capillary","volume":"41","author":"Armstrong","year":"1990","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0b013e3181cdc3e2","article-title":"Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways","volume":"34","author":"Kreth","year":"2010","journal-title":"Shock"},{"issue":"9","key":"10.1016\/j.mehy.2020.110051_b0095","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1096\/fj.13-228122","article-title":"Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent","volume":"27","author":"Konrad","year":"2013","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0100","first-page":"2210","article-title":"Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A","volume":"8","author":"Li","year":"2016","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0049-3848(77)90019-6","article-title":"The effect of dipyridamole on adenosine uptake by platelets ex vivo","volume":"11","author":"Summers","year":"1977","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2020.110051_b0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phrs.2014.05.008","article-title":"Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?","volume":"87","author":"Balakumar","year":"2014","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0120","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1084\/jem.158.4.1160","article-title":"Adenosine: a physiological modulator of superoxide anion generation by human neutrophils","volume":"158","author":"Cronstein","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.110051_b0125","doi-asserted-by":"crossref","unstructured":"Le V, V, Chen YL, Masson I et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 1993;52(24):1917-24.","DOI":"10.1016\/0024-3205(93)90632-D"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0090-6980(85)90156-X","article-title":"Prostacyclin production by rat aorta \u201cin vitro\u201d is increased by the combined action of dipyridamole plus pentoxifylline","volume":"29","author":"Santos","year":"1985","journal-title":"Prostaglandins"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1055\/s-0038-1660158","article-title":"Effect of dipyridamole plus pentoxifylline in patients with diffuse cerebrovascular insufficiency","volume":"54","author":"Yaya","year":"1985","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0049-3848(93)90189-U","article-title":"Effects of dipyridamole, pentoxifylline or dipyridamole plus pentoxifylline on platelet reactivity in patients with ischemic cerebrovascular insufficiency","volume":"72","author":"Santos","year":"1993","journal-title":"Thromb Res"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2020.110051_b0145","first-page":"401","article-title":"Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock","volume":"27","author":"Barroso-Aranda","year":"1990","journal-title":"Biorheology"},{"key":"10.1016\/j.mehy.2020.110051_b0150","first-page":"97","article-title":"Pentoxifylline pretreatment decreases neutrophil activation during endotoxic shock and improves survival. Pentoxifylline and analogues: Effects on leukocyte function.Basel","author":"Barroso-Aranda","year":"1990","journal-title":"Skarger"},{"key":"10.1016\/j.mehy.2020.110051_b0155","doi-asserted-by":"crossref","unstructured":"Deree J, Martins J, de CT et al. Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock. J Surg Res 2007 November;143(1):99-108.","DOI":"10.1016\/j.jss.2007.03.083"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0160","first-page":"331","article-title":"Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized study","volume":"1","author":"Ardizzoia","year":"1993","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.mehy.2020.110051_b0165","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/HJH.0000000000001086","article-title":"Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Brie","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2020.110051_b0170","doi-asserted-by":"crossref","unstructured":"Levi M, ten CH, Bauer KA et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994 January;93(1):114-20.","DOI":"10.1172\/JCI116934"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0175","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1164\/ajrccm\/144.6.1347","article-title":"Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils","volume":"144","author":"McDonald","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0162-3109(99)00186-1","article-title":"Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells","volume":"46","author":"Krakauer","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.mehy.2020.110051_b0185","unstructured":"Bermejo Martin JF, Jimenez JL, Munoz-Fernandez A. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med Sci Monit 2003 June;9(6):SR29-SR34."},{"key":"10.1016\/j.mehy.2020.110051_b0190","doi-asserted-by":"crossref","unstructured":"Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002 January;30(1):1-6.","DOI":"10.1097\/00003246-200201000-00001"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2004.08.012","article-title":"Lisofylline: a potential lead for the treatment of diabetes","volume":"69","author":"Yang","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0922-4106(92)90157-Q","article-title":"Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes","volume":"227","author":"Suzuki","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0205","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0003-4975(99)00173-3","article-title":"Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery","volume":"67","author":"Chello","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.mehy.2020.110051_b0210","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1468-1331.2007.01847.x","article-title":"Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan","volume":"14","author":"Hallevi","year":"2007","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0215","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0049-3848(90)90293-L","article-title":"Dipyridamole inhibits O2- release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide","volume":"60","author":"Brozna","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2020.110051_b0225","first-page":"20","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"April","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.mehy.2020.110051_b0230","first-page":"29","article-title":"Dipyridamole as an inhibitor of vaccinia virus replication","volume":"1","author":"Korbecki","year":"1985","journal-title":"Mol Gen Mikrobiol Virusol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1096-9071(199610)50:2<198::AID-JMV15>3.0.CO;2-I","article-title":"Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model","volume":"50","author":"Hay","year":"1996","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.mehy.2020.110051_b0240","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/AAC.45.12.3657-3659.2001","article-title":"Inhibition of herpes simplex virus reactivation by dipyridamole","volume":"45","author":"Tenser","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"10.1016\/j.mehy.2020.110051_b0245","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1128\/JVI.79.17.11062-11070.2005","article-title":"Dipyridamole reversibly inhibits mengovirus RNA replication","volume":"79","author":"Fata-Hartley","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.110051_b0250","first-page":"26","article-title":"Epidemiological trial of the prophylactic effectiveness of the interferon inducer dipyridamole with respect to influenza and acute respiratory diseases","volume":"6","author":"Kuzmov","year":"1985","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"178","key":"10.1016\/j.mehy.2020.110051_b0255","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"3","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110051_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1889","article-title":"The approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19","author":"Schmith","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.mehy.2020.110051_b0265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.mehy.2020.110051_b0270","doi-asserted-by":"crossref","unstructured":"DiNicolantonio JJ, Barroso-Aranda J, McCarty MF. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. submittted for publication 2020.","DOI":"10.1136\/openhrt-2020-001350"},{"issue":"11","key":"10.1016\/j.mehy.2020.110051_b0275","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1172\/JCI63170","article-title":"Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury","volume":"122","author":"Li","year":"2012","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.mehy.2020.110051_b0280","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.4049\/jimmunol.169.8.4262","article-title":"Pentoxifylline functions as an adjuvant in vivo to enhance T cell immune responses by inhibiting activation-induced death","volume":"169","author":"Suresh","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.mehy.2020.110051_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071251","article-title":"Beta glucan: supplement or drug? From laboratory to clinical trials","volume":"24","author":"Vetvicka","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/07315724.2012.10720441","article-title":"Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women","volume":"31","author":"Talbott","year":"2012","journal-title":"J Am Coll Nutr"},{"issue":"Pt A","key":"10.1016\/j.mehy.2020.110051_b0295","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijbiomac.2016.06.057","article-title":"Improvement of immune responses to influenza vaccine (H5N1) by sulfated yeast beta-glucan","volume":"93","author":"Wang","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0300","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00134-005-2629-x","article-title":"Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats","volume":"31","author":"Babayigit","year":"2005","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.shk.0000245030.24235.f1","article-title":"Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis","volume":"27","author":"Bedirli","year":"2007","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0310","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ajcn\/85.3.837","article-title":"Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress","volume":"85","author":"Prasad","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.mehy.2020.110051_b0315","first-page":"4539","article-title":"Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"24","author":"Meo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.mehy.2020.110051_b0320","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2020.110051_b0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0330","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"issue":"2 Suppl 1","key":"10.1016\/j.mehy.2020.110051_b0335","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0340","first-page":"58","article-title":"Delineation of chicken cathepsin L secondary structure; relationship between pH dependence activity and helix content","volume":"955","author":"Dufour","year":"1988","journal-title":"BBA"},{"issue":"5","key":"10.1016\/j.mehy.2020.110051_b0345","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"Muller-Calleja","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2020.110051_b0350","article-title":"The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","volume":"29","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.mehy.2020.110051_b0355","doi-asserted-by":"crossref","unstructured":"Mercuro NJ, Yen CF, Shim DJ et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020 May 1.","DOI":"10.1001\/jamacardio.2020.1834"},{"key":"10.1016\/j.mehy.2020.110051_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.mehy.2020.110051_b0365","article-title":"Experience with hydroxychloroquine and azithromycin in the COVID-19 pandemic: implications for QT interval monitoring","volume":"28","author":"Ramireddy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mehy.2020.110051_b0370","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Shen B et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020 March 25.","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"10.1016\/j.mehy.2020.110051_b0375","article-title":"Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol","volume":"6","author":"Naksuk","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.mehy.2020.110051_b0380","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwaa093","article-title":"Early outpatient treatment of symptomatic, high-risk covid-19 patients that should be ramped-up immediately as key to the pandemic crisis","author":"Risch","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2020.110051_b0385","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1857","article-title":"Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19","author":"Damle","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110051_b0390","article-title":"Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak","volume":"20","author":"Conforti","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.mehy.2020.110051_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.02.007","article-title":"Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus","author":"McCarty","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.mehy.2020.110051_b0400","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.celrep.2019.07.085","article-title":"MAVS O-GlcNAcylation is essential for host antiviral immunity against lethal RNA viruses","volume":"28","author":"Song","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.mehy.2020.110051_b0405","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3389\/fphys.2019.01614","article-title":"Acute increase in O-GlcNAc improves survival in mice with LPS-induced systemic inflammatory response syndrome","volume":"10","author":"Silva","year":"2019","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0410","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1074\/jbc.RA118.004638","article-title":"Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation","volume":"294","author":"Hwang","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2020.110051_b0415","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.01.026","article-title":"Glucosamine attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling","volume":"69","author":"Wu","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0420","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1165\/rcmb.2013-0022OC","article-title":"Attenuation of LPS-induced lung inflammation by glucosamine in rats","volume":"49","author":"Chuang","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.mehy.2020.110051_b0425","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/ATVBAHA.117.310468","article-title":"O-Linked beta-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-kappaB (Nuclear Factor-kappaB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury","volume":"38","author":"Yao","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"142","key":"10.1016\/j.mehy.2020.110051_b0430","article-title":"Targeting Casein kinase 2 with quercetin or enzymatically modified isoquercitrin as a strategy for boosting the type 1 interferon response to viruses and promoting cardiovascular health","volume":"4","author":"DiNicolantonio","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2020.110051_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109984","article-title":"Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling","volume":"125","author":"Peng","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2020.110051_b0440","first-page":"2;12(4)","article-title":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"April","author":"Grant","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.mehy.2020.110051_b0445","article-title":"Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity","author":"Rhodes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110051_b0450","article-title":"Does vitamin D status impact mortality from SARS-CoV-2 infection?","volume":"29","author":"Marik","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.mehy.2020.110051_b0455","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2016.11.004","article-title":"Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro","volume":"137","author":"Telcian","year":"2017","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0460","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jcp.1041420327","article-title":"Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages","volume":"142","author":"Pryke","year":"1990","journal-title":"J Cell Physiol"},{"issue":"Pt 1","key":"10.1016\/j.mehy.2020.110051_b0465","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1099\/vir.0.045013-0","article-title":"The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins","volume":"94","author":"Tripathi","year":"2013","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.mehy.2020.110051_b0470","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2174\/0929867326666190805151654","article-title":"Antiviral activities of human host defense peptides","volume":"27","author":"Brice","year":"2020","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0475","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jcv.2010.12.006","article-title":"Vitamin D and the anti-viral state","volume":"50","author":"Beard","year":"2011","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0480","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41467-018-03314-9","article-title":"Mechanistic insights into allosteric regulation of the A2A adenosine G protein-coupled receptor by physiological cations","volume":"9","author":"Ye","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0485","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0039-3402808","article-title":"Reduced plasma magnesium levels in type-1 diabetes associate with prothrombotic changes in fibrin clotting and fibrinolysis","volume":"120","author":"Sobczak","year":"2020","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0490","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18087\/cardio.2018.4.10106","article-title":"Deficit of magnesium and states of hypercoagulation: intellectual analysis of data obtained from a sample of patients aged 18\u201350 years from medical and preventive facilities in Russia","volume":"58","author":"Gromova","year":"2018","journal-title":"Kardiologiia"},{"issue":"1","key":"10.1016\/j.mehy.2020.110051_b0495","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCA.0000000000000318","article-title":"Magnesium as a predictor of acute stent thrombosis in patients with ST-segment elevation myocardial infarction who underwent primary angioplasty","volume":"27","author":"Cicek","year":"2016","journal-title":"Coron Artery Dis"},{"issue":"4","key":"10.1016\/j.mehy.2020.110051_b0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF02982655","article-title":"Antithrombotic effects of magnesium sulfate in in vivo experiments","volume":"77","author":"Sheu","year":"2003","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0505","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mhj.2000.107553","article-title":"Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease","volume":"140","author":"Shechter","year":"2000","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.mehy.2020.110051_b0510","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/SHK.0000000000000769","article-title":"Does hypomagnesemia impact on the outcome of patients admitted to the intensive care unit? A systematic review and meta-analysis","volume":"47","author":"Jiang","year":"2017","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.mehy.2020.110051_b0515","first-page":"15","article-title":"Hypomagnesemia in the","volume":"64","author":"Charles","year":"2016","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"10.1016\/j.mehy.2020.110051_b0520","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jss.2012.04.045","article-title":"Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro","volume":"180","author":"Liu","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.mehy.2020.110051_b0525","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/JIR.S136742","article-title":"Magnesium deficiency and increased inflammation: current perspectives","volume":"11","author":"Nielsen","year":"2018","journal-title":"J Inflamm Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720317382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720317382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:02Z","timestamp":1759692302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720317382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":105,"alternative-id":["S0306987720317382"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110051","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110051"}}